Systematic literature review (SLR) is foundational to evidence generation in life sciences.
Epidemiology teams, health economists, and clinical researchers rely on systematic reviews to quantify disease burden, evaluate treatment outcomes, and support regulatory submissions and health technology assessments (HTAs). But as biomedical literature continues to grow, conducting rigorous systematic reviews has become increasingly difficult.
PubMed contains over 39 million citations and abstractions for biomedical literature. For research teams conducting systematic reviews, this means identifying relevant evidence within an ever-expanding universe of publications.
The challenge is no longer finding studies. It’s identifying the right studies efficiently and reproducibly. That’s where the balance between recall and precision becomes critical.
Why recall alone creates new problems
In information retrieval, two metrics are commonly used to evaluate search performance:
Recall measures how many relevant studies are successfully retrieved.
Precision measures how many retrieved studies are actually relevant.
In systematic review, recall is often prioritized to minimize the risk of missing important evidence. However, maximizing recall without considering precision can create significant downstream challenges.
Traditional search strategies frequently return thousands of citations, many of which are irrelevant to the research question. A typical systematic review may require screening 5,000–20,000 abstracts before identifying eligible studies. For evidence teams, that means weeks or months of manual screening, significant reviewer workload with risk of fatigue and inconsistency, and higher research costs.
In other words, low precision shifts the burden of filtering evidence onto researchers. And as the volume of biomedical literature grows, that burden only increases.
The downstream impact of low precision
Search is only the first step in a systematic literature review. Once studies are retrieved, researchers must move through several stages of evaluation:
- Abstract screening
- Full-text screening
- Data extraction
- Evidence synthesis
- Reporting and PRISMA documentation
Each stage depends on the quality of the evidence set generated at the start.
When thousands of irrelevant citations enter the pipeline, the entire workflow becomes slower and more resource-intensive. Screening takes longer, extraction becomes more complex, and timelines for evidence synthesis expand. This is why experienced systematic review teams don’t simply aim for maximum recall. They aim for high recall with controlled precision, ensuring that relevant evidence is captured without overwhelming the review process.
Why precision is difficult to achieve in systematic literature review
Achieving both recall and precision is challenging because biomedical knowledge is expressed using highly variable terminology.
The same disease, treatment, or outcome may be described differently across publications due to:
- Evolving clinical definitions
- Differences in diagnostic terminology
- Regional naming conventions
- Variations in outcome reporting
Traditional keyword-based search strategies struggle with this variability. Expanding queries with additional synonyms can improve recall but often introduces large volumes of irrelevant results. Addressing this challenge requires moving beyond simple keyword matching toward concept-based retrieval grounded in clinical knowledge.
For a deeper look at how structured clinical terminology improves literature search strategies, see our related post: Why clinical terminology is the missing link in the systematic review process.
Precision matters across the entire review workflow
The discussion around recall and precision often focuses only on search. But these tradeoffs affect every stage of systematic review.
Emerging AI-enabled platforms are beginning to apply automation across the full SLR workflow, from screening to data extraction, while maintaining transparency and human oversight.
For example:
AI-assisted screening can prioritize relevant studies and reduce manual review effort.
Full-text analysis can help identify eligibility criteria directly within study content.
Automated extraction tools can capture epidemiologic variables such as incidence, prevalence, and mortality rates.
When implemented correctly, these approaches help evidence teams focus their time on interpreting data rather than filtering noise.
Moving from article retrieval to evidence generation
As AI becomes more integrated into systematic review workflows, expectations are changing.
The goal is no longer simply to retrieve more articles faster. Instead, the focus is shifting toward building precision-driven evidence workflows that support reproducible research.
That means combining:
- Concept-based search strategies
- Transparent AI-assisted screening
- Structured data extraction
- Human validation
When these elements work together, systematic review can shift from a months-long manual process toward a more scalable approach to evidence generation. And for epidemiology teams tasked with answering increasingly complex research questions, that shift can make a significant difference.
Because in systematic review, success isn’t defined by how many articles you retrieve. It’s defined by how confidently you can identify the evidence that actually matters.
